OakChart

Bruker Corp

BRKRHealthcare·Medical Devices·USA·Mid·NASD·Nov 11 • 8:21 AM ET

63.22+0.98 (1.58%)
2026-11-11 14:28 CET
Market cap
9,505.42 USD m
Revenue, TTM
3,513.10 USD m
Net income, TTM
-167.30 USD m
Free cash flow, TTM
244.70 USD m
EPS diluted, TTM
-1.10
P/E
-
Compare

Price

BRKR against its 20, 50 and 200-day averages
2050200miss
40.0050.0060.0070.004.4M8.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BRKRclose 63.2220-day 59.2050-day 59.43200-day 50.6663.22

8.4% under 68.98 on 4 Nov 2026. Last 15 sessions, 25.1% high to low

Profile

BRKR
52-week range, 84% of the way up
32.3768.98

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI NANO, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI NANO segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Gunther Laukien in 1960 and is headquartered in Billerica, MA.

IndexRUI
Employees11085
IPOAug 04, 2000
Beta1.25
ATR, 14d3.98
Rel volume0.15
Short float10.11%
Insider own27.15%
Inst own92.78%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap9.66B
Enterprise Value11.26B
Income-167.30M
Sales3.51B
Book/sh14.97
Cash/sh1.09
Dividend Est.0.15 (0.24%)
Dividend TTM0.20 (0.32%)
Dividend Ex-DateSep 21, 2026
Dividend Gr. 3/5Y0.00% 4.56%
Payout-
Employees11085
IPOAug 04, 2000

Ratios

P/E-
Forward P/E25.92
PEG1.69
P/S2.75
P/B4.22
P/C57.82
P/FCF39.46
EV/EBITDA19.34
EV/Sales3.20
Quick Ratio0.90
Current Ratio1.84
Debt/Eq0.75
LT Debt/Eq0.75
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.10
EPS next Y2.44
EPS next Q0.77
EPS this Y16.24%
EPS next Y14.67%
EPS next 5Y15.31%
EPS past 3/5Y- -
Sales past 3/5Y10.74% 11.57%
EPS Y/Y TTM-604.24%
Sales Y/Y TTM2.16%
EPS Q/Q-95.86%
Sales Q/Q1.57%
EarningsNov 04 BMO
EPS/Sales Surpr.33.65% 1.02%

Ownership

Insider Own27.15%
Insider Trans-0.03%
Inst Own92.78%
Inst Trans3.50%
ROA-2.01%
ROE-5.23%
ROIC-3.09%
Gross Margin47.97%
Oper. Margin10.07%
Profit Margin-4.76%
SMA206.79%
SMA506.38%
SMA20024.78%
Trades-

Technical

Shs Outstand152.72M
Shs Float111.26M
Short Float10.11%
Short Ratio4.91
Short Interest11.25M
52W High68.98 -8.35%
52W Low32.37 95.34%
Volatility9.13% 5.97%
ATR (14)3.98
RSI (14)55.01
Beta1.25
Rel Volume0.15
Avg Volume2.29M
Volume17,115

Performance

Perf Week-0.89%
Perf Month12.51%
Perf Quarter9.13%
Perf Half Y44.17%
Perf YTD34.20%
Perf Year51.50%
Perf 3Y9.36%
Perf 5Y-23.06%
Perf 10Y176.43%
Recom2.36
Target Price68.00
Prev Close62.24
Price63.22
Change %1.58%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 14, 2026DowngradeJJP MorganOverweight → Neutral$60-5.1%
Sep 09, 2026InitiatedUUBSNeutral$65+2.8%
Jun 02, 2026ResumedWWolfe ResearchPeer Perform
Dec 10, 2025UpgradeWWolfe ResearchPeer Perform → Outperform$60-5.1%
Dec 09, 2025InitiatedGGoldmanSell$40-36.7%
Nov 20, 2025InitiatedRRothschild & Co RedburnBuy$60-5.1%
May 22, 2025DowngradeCCitigroupBuy → Neutral$40-36.7%
Dec 19, 2024InitiatedGGuggenheimBuy$72+13.9%
Dec 10, 2024InitiatedUUBSNeutral$66+4.4%
Dec 05, 2024UpgradeGGoldmanSell → Neutral$60-5.1%

Peers

Mkt cap
TickerCompanyMkt cap
BIOBio-Rad Laboratories Inc10.41B
TXG10x Genomics Inc8.47B
WATWaters Corp46.74B
AAgilent Technologies Inc50.18B
TMOThermo Fisher Scientific Inc265.76B
MTDMettler-Toledo International Inc34.84B
DHRDanaher Corp165.72B
TECHBio-Techne Corp11.41B
QGENQiagen NV10.39B
LABStandard BioTools Inc267.79M

Insider trading

latest 14 of 38
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Munch MarkEXEC VP&PRES BRUKER NANO INC.Sep 15 '26Option Exercise22.192,00044,380136,806Sep 16 04:15 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Sep 15 '26Sale52.872,000105,740134,806Sep 16 04:15 PM
MARK R MUNCHOfficerSep 15 '26Proposed Sale52.872,000105,740Sep 15 04:19 PM
Pusch WolfgangPresident BMID GroupAug 17 '26Sale56.903,473197,6149,801Aug 18 04:15 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Aug 14 '26Option Exercise22.192,00044,380125,347Aug 18 04:15 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Aug 14 '26Sale57.602,000115,200123,347Aug 18 04:15 PM
WOLFGANG PUSCHOfficerAug 17 '26Proposed Sale56.903,473197,614Aug 17 04:07 PM
MARK R MUNCHOfficerAug 14 '26Proposed Sale57.602,000115,200Aug 14 04:34 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Jul 15 '26Option Exercise22.192,00044,380130,443Jul 16 04:15 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Jul 15 '26Sale60.252,000120,500128,443Jul 16 04:15 PM
MARK R MUNCHOfficerJul 15 '26Proposed Sale60.252,000120,500Jul 15 04:12 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Jun 15 '26Option Exercise22.192,00044,380130,443Jun 16 04:15 PM
Munch MarkEXEC VP&PRES BRUKER NANO INC.Jun 15 '26Sale54.762,000109,520128,443Jun 16 04:15 PM
MARK R MUNCHOfficerJun 15 '26Proposed Sale54.762,000109,520Jun 15 04:38 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.95B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
FBTFirst Trust NYSE Arca Biotechnology Index FundAUM: 3.05B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.82B
VXFVanguard Extended Market Index ETFAUM: 30.61B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.57B
IBBiShares Biotechnology ETFAUM: 11.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.35B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.97B

News

latest 14 of 206
  • Bruker's Margin-Led Beat Outruns A Flat Top Line As Bookings Recovery Broadens (Earnings Whispers) +12.90%
  • Bruker: Q3 Earnings Snapshot (Associated Press)
  • Bruker Reports Third Quarter 2026 Financial Results (Business Wire)
  • Bruker's Planned Soft Quarter Puts Spotlight On Bookings And A $1 Billion Fourth Quarter (Earnings Whispers)
  • Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast (Business Wire) +5.68%
  • Loading…
  • Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution (Business Wire) -5.26%
  • Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research (Business Wire)
  • Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley (Business Wire)
  • Bruker Corporation to Present at Upcoming Investor Conferences (Business Wire)
  • BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP Superconductors for Magnetic Confinement Fusion (Business Wire)
  • Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories (Business Wire)
  • Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development (Business Wire) +5.45%
  • Bruker Corp (BRKR) (Q2 2026) Earnings Call Highlights: Organic Growth Returns, Margins Surge, ... (GuruFocus.com) -21.79%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.5600.419-0.810874865.1613
2026Q22026-08-040.4900.385-0.413838.5853.5713
2026Q12026-05-060.3100.2290.023823.4795.6214
2025Q42026-02-120.5900.6500.098977.2962.2615
2025Q32025-11-030.4500.354-0.411860.5849.1814
2025Q22025-08-040.3200.4120.050797.4810.1414
2025Q12025-05-070.4700.4360.115801.4768.5115
2024Q42025-02-130.7600.7370.090979.6975.215
2024Q32024-11-050.6000.6010.269864.4866.4613
2024Q22024-08-060.5200.5130.051800.7799.4711
2024Q12024-05-020.5300.4650.349721.7729.8811
2023Q42024-02-130.7000.6831.408854.5807.4512
2023Q32023-11-020.7400.6330.598742.8714.6111
2023Q22023-08-030.5000.4870.387681.9647.8211
2023Q12023-05-040.6400.5490.518685.3639.7611
2022Q42023-02-090.7400.7220.659708.4680.111

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.5711.6301.2592,0732,045
2020FY1.3501.3301.0211,9881,963
2021FY2.1002.0931.8122,4182,398
2022FY2.3402.3201.9852,5312,501
2023FY2.5802.5472.9022,9652,916
2024FY2.4102.3870.7573,3663,362
2025FY1.8301.884-0.1503,4373,422
2026FY-2.127--3,540
2027FY-2.439--3,689
2028FY-2.806--3,893
2029FY-3.201--4,139
2030FY-3.470--4,390

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-04110111,003988.951,009
2026Q4S2026-10-1811101,0271,0211,041
2026Q4S2026-10-1311801,0271,0211,041
2026Q4S2026-10-0911801,0271,0211,041
2026Q4S2026-10-0811801,0271,0211,041
2026Q4S2026-10-0611801,0271,0211,041
2026Q4S2026-09-3011801,0281,0211,041
2026Q4S2026-09-2811701,0261,0211,033
2026Q4S2026-09-0812701,0261,0211,033
2026Q4S2026-08-0411701,0261,0211,033
2026Q4S2026-07-2111001,0141,0061,022
2026Q4S2026-07-2011011,0141,0061,022
2026Q4S2026-06-2511071,0141,0061,022
2026Q4S2026-06-1311071,0141,0061,022

Estimate history

EPS, annual0.4941.1431.2591.0211.8121.9852.9020.757-0.148-1.0976
Period201720182019202020212022202320242025TTM
EPS, quarterly0.2690.090.1150.05-0.4110.0980.023-0.413-0.805
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1765.91895.62072.61987.52417.92530.72964.53366.43436.53513.1
Period201720182019202020212022202320242025TTM
Sales, quarterly864.4979.6801.4797.4860.5977.2823.4838.5874
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual155.866156.609154.156151.987150.754147.023145.165151.678152.143152.722
Period201720182019202020212022202320242025MRQ
Shares, quarterly151.595151.678151.521151.716151.392152.143152.223152.353152.722
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,513.103,436.503,366.402,964.502,530.702,417.901,987.502,072.601,895.60
Cost of Goods Sold Incl. D&A1,828.001,798.501,705.301,447.701,224.101,204.901,043.901,070.80992.40
Gross Profit1,685.101,638.001,661.101,516.801,306.601,213.00943.601,001.80903.20
Selling, General and Administrative Excl. Other1,324.701,341.701,270.301,024.20843.30782.00666.60687.90618.10
Research and Development387.20395.20376.50294.80235.90220.80198.00187.70173.40
Other Operating Expense6.7016.1011.0010.303.802.802.500.004.80
Operating Income353.70280.20379.80482.30459.50428.20274.50313.90280.30
Interest Expense56.6060.3047.9016.4016.1014.3014.4016.0012.60
Unusual Expense394.30236.20138.2031.8021.5014.8016.508.6024.70
Net Income Before Taxes-70.9022.00206.90544.20413.90393.60225.80280.40244.70
Income Taxes42.3029.3091.40117.70116.40113.0064.4082.4063.70
Consolidated Net Income-115.70-8.30113.80428.50298.50280.60161.40198.00181.00
Net Income From Continuing Operations-123.40-8.60113.10427.20296.60277.10157.80197.20179.70
Net Income-167.30-22.50113.10427.20296.60277.10157.80197.20179.70
EPS (Recurring)0.710.941.403.052.091.881.101.301.25
EPS (Basic, Before Extraordinaries)-1.10-0.150.762.922.001.831.031.271.15
EPS (Diluted)-1.10-0.150.762.901.991.811.021.261.14
EBITDA582.20500.50563.60597.20548.30517.40355.00389.50345.20
Non-Operating Income (Expense)26.3038.3013.20110.10-8.00-5.50-17.80-8.901.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.0415.8017.1414.5412.4014.509.718.698.93
Price To Earnings Ratio--28.2333.9937.4246.2852.9040.3926.05
Price To Sales Ratio2.812.082.603.654.045.314.213.852.47
Gross Margin47.9747.6649.3451.1751.6350.1747.4848.3447.65
Operating Margin10.078.1511.2816.2718.1617.7113.8115.1514.79
Net Margin-4.76-0.653.3614.4111.7211.467.949.519.48
Shares Outstanding152.72152.14151.68145.16147.02150.75151.99154.16156.61
Market Capitalization9,505.429,505.428,886.6710,170.4410,053.1212,725.378,287.747,848.974,662.26

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue874.00838.50823.40977.20860.50797.40801.40979.60
Cost of Goods Sold Incl. D&A444.10422.20434.10527.60460.90435.10407.60484.50
Gross Profit429.90416.30389.30449.60399.60362.30393.80495.10
Selling, General and Administrative Excl. Other318.50333.20343.40329.60340.80331.60322.50351.70
Research and Development92.0094.30101.3099.6098.30100.2097.10104.40
Other Operating Expense1.501.100.903.203.602.803.0051.00
Operating Income109.9082.0045.00116.8055.2027.9068.3092.40
Interest Expense15.4017.8012.2011.2020.3015.7013.1015.60
Unusual Expense207.80117.4033.7035.40114.9036.4032.3020.00
Net Income Before Taxes-120.30-40.7021.9068.20-71.800.5025.1056.10
Income Taxes-12.2014.202.5037.80-14.10-3.108.7040.70
Consolidated Net Income-109.70-50.9015.7029.20-58.504.2016.8013.90
Net Income From Continuing Operations-111.80-52.0014.4026.00-59.607.6017.4013.70
Net Income-122.80-62.903.5014.90-62.407.6017.4013.70
EPS (Recurring)0.150.130.180.260.120.220.260.18
EPS (Basic, Before Extraordinaries)-0.81-0.410.020.10-0.410.050.110.09
EPS (Diluted)-0.81-0.410.020.10-0.410.050.110.09
EBITDA164.00140.00103.30174.90110.9084.00118.70145.30
Non-Operating Income (Expense)-7.0012.5022.80-2.008.2024.702.20-0.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.824.424.742.054.744.504.424.82
Price To Earnings Ratio----62.0278.4654.9628.23
Price To Sales Ratio2.812.621.592.091.431.821.842.65
Gross Margin49.1949.6547.2846.0146.4445.4449.1450.54
Operating Margin12.579.785.4711.956.413.508.529.43
Net Margin-14.05-7.500.431.52-7.250.952.171.40
Shares Outstanding152.72152.35152.22152.14151.39151.72151.52151.68
Market Capitalization9,505.429,160.965,498.157,157.944,929.356,243.126,332.178,886.67

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments298.80183.40488.30645.501,168.20731.80684.90322.40439.20
Short Term Receivables736.00701.20621.80534.00463.00377.10406.10383.10319.30
Inventories1,094.601,067.80968.30800.10710.10692.30577.20509.60486.20
Other Current Assets83.10100.8085.80133.60130.50123.80128.1089.20114.10
Total Current Assets2,212.502,053.202,164.202,113.202,471.801,925.001,796.301,304.301,358.80
Net Property, Plant & Equipment910.60814.80691.40538.20466.00462.90371.70270.60266.50
Total Investments and Advances8.2025.308.3023.000.000.000.000.200.00
Intangible Assets2,447.302,419.80913.10728.50551.30549.50526.20494.40252.20
Deferred Tax Assets421.70286.20297.2076.8090.1072.0060.5050.9057.00
Other Assets241.10207.40175.70132.1070.8039.6016.808.2014.00
Total Assets6,241.405,806.704,249.903,611.803,650.003,049.002,771.502,128.601,948.50
Short Term Debt Incl. Current Port. of LT Debt51.8064.60144.5035.10130.3023.5021.1018.500.00
Accounts Payable215.90234.10202.70178.40147.40134.60118.40104.5090.80
Income Tax Payable76.20119.60138.7085.5075.1098.0052.4036.8028.10
Other Current Liabilities935.30863.00716.20615.30585.70535.80453.70439.50405.60
Total Current Liabilities1,279.201,281.301,202.10914.30938.50791.90645.60599.30524.50
Long Term Debt1,991.102,180.701,235.101,235.301,263.60889.30859.80322.60415.60
Provision for Risks Charges0.00103.0076.6045.70104.70123.40122.4090.50105.60
Deferred Tax Liabilities112.50118.5067.7062.3046.0043.1048.8051.3024.50
Other Liabilities348.30308.00255.10222.40212.40227.00156.70137.20144.80
Total Liabilities3,731.103,991.502,836.602,480.002,565.202,074.701,833.301,200.901,215.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity2,456.501,781.201,377.201,113.801,070.50961.20906.80896.60725.40
Total Shareholders Equity2,456.501,781.201,377.201,113.801,070.50961.20906.80896.60725.40
Accumulated Minority Interest53.8034.0036.1018.0014.3013.1031.4031.108.10
Total Equity2,510.301,815.201,413.301,131.801,084.80974.30938.20927.70733.50
Total Liabilities & Stockholders Equity6,241.405,806.704,249.903,611.803,650.003,049.002,771.502,128.601,948.50
Book Value Per Share16.1511.749.497.587.106.325.885.734.65
Tangible Book Value Per Share0.06-4.213.202.623.442.712.472.573.04
Full-Time Employees11,08511,3969,7078,5257,7657,4007,2306,8706,200
Price to Book Ratio4.164.928.8710.7511.828.568.665.207.32
Return on Assets-0.142.2510.878.178.275.428.058.824.18
Return on Equity-0.417.1634.3027.1627.2816.9021.8722.1611.13
Return on Invested Capital-0.192.8516.3512.6311.878.5311.1614.746.89
Quick Ratio0.870.770.991.441.881.561.891.331.66
Current Ratio1.731.601.802.312.632.432.782.182.59

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-115.70-8.30113.80428.50298.50280.60161.40198.00181.00
Depreciation228.50220.30183.80114.9088.8089.1080.4075.6064.90
Other Funds (Non Cash)468.00171.4095.70-81.1046.0044.1043.3019.7051.10
Funds from Operations452.00278.90329.50437.90418.50408.00262.60287.90281.90
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-110.20-144.80-78.20-87.80-144.10-125.6069.60-74.50-42.20
Income Taxes Payable--94.00-15.3043.70-6.80-44.3042.9013.104.00
Cash from Operating Activities341.80134.10251.30350.10274.40282.40332.20213.40239.70
Capital Expenditures-97.10-90.80-115.30-106.90-129.20-92.00-97.20-73.00-49.20
Net Assets From Acquisitions-77.20-73.90-1,614.30-226.60-182.30-65.00-60.40-90.00-191.60
Sale of Fixed Assets and Businesses0.000.001.1014.1013.904.900.2011.000.40
Purchase or Sale of Investments-7.20-7.20-48.30-10.0039.80-50.30-43.90-6.40117.00
Purchase of Investments-7.20-7.20-48.30-24.80-60.20-148.50-150.00-6.400.00
Sale Or Maturity of Investments--0.0014.80100.0098.20106.100.00117.00
Other Uses-26.30-29.400.000.000.000.00-1.200.000.00
Other Sources14.604.804.806.406.2010.008.600.000.00
Cash from Investing Activities-193.20-196.50-1,772.00-323.00-251.60-192.40-193.90-158.40-123.40
Cash Dividends Paid-63.30-22.80-30.20-29.40-29.80-24.20-24.60-25.00-25.10
Change in Capital Stock4.00667.60409.00-142.80-260.30-146.30-119.90-131.409.40
Repurchase of Common Pref Stock0.00-10.000.00-152.30-263.10-153.30-123.20-142.300.00
Sale of Common Pref Stock4.00677.60409.009.502.807.003.3010.909.40
Proceedsfrom Stock Options4.00677.60409.009.502.807.003.3010.909.40
Issuance or Reduction of Debt, Net-215.90-491.30870.40-21.50-110.70489.60-8.40462.60-93.50
Change in Long Term Debt-215.90-491.30870.40-21.50-110.70489.60-8.40462.60-93.50
Issuance of Long Term Debt215.60754.002,218.500.000.30492.70297.40844.10129.40
Reduction of Long Term Debt-431.50-1,245.30-1,348.10-21.50-111.00-3.10-305.80-381.50-222.90
Net Financing Active Other Cash Flow-58.20-18.40-4.70-2.70-14.50-0.40-7.50-6.20-3.20
Other Financing Activities Uses-57.10-18.40-4.70-2.70-14.50-0.40-7.50-6.20-3.20
Cash from Financing Activities-333.40135.101,244.50-196.40-415.30318.70-160.40300.00-112.40
Exchange Rate Effect11.3043.70-28.7012.20-30.50-22.5025.700.60-6.50
Net Change in Cash-173.50116.40-304.90-157.10-423.00386.203.60355.60-2.60
Free Cash Flow244.7043.30136.00243.20145.20190.40235.00140.40190.50
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Price to Free Cash Flow54.43348.8482.8350.5988.4977.2039.7769.1728.29
Deferred Taxes & Investment Tax Credit--104.50-63.80-24.40-14.80-5.80-22.50-5.40-15.10

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments167.00222.50133.40298.80293.1092.00
Short Term Receivables793.00776.60750.40736.00766.70738.70
Inventories1,102.701,120.101,121.501,094.601,196.601,218.30
Other Current Assets94.40105.8098.3083.1094.20113.70
Total Current Assets2,157.102,225.002,103.602,212.502,350.602,162.70
Net Property, Plant & Equipment695.70714.10719.60910.60746.70758.50
Total Investments and Advances19.7014.8025.908.2027.3040.60
Intangible Assets2,148.802,297.602,475.302,447.302,468.802,618.80
Deferred Tax Assets---421.70--
Other Assets807.00801.40806.30241.10841.50759.20
Total Assets5,828.306,052.906,130.706,241.406,434.906,339.80
Short Term Debt Incl. Current Port. of LT Debt10.4010.108.4051.8024.3055.70
Accounts Payable207.80200.20269.10215.90184.40243.00
Income Tax Payable---76.20--
Other Current Liabilities953.90994.401,077.60935.301,059.401,048.70
Total Current Liabilities1,172.101,204.701,355.101,279.201,268.101,347.40
Long Term Debt1,703.001,814.701,662.901,991.101,984.202,379.60
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---112.50--
Other Liabilities610.20597.70609.90348.30690.20746.00
Total Liabilities3,485.303,617.103,627.903,731.103,942.504,473.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity2,285.602,381.402,449.102,456.502,431.901,804.00
Total Shareholders Equity2,285.602,381.402,449.102,456.502,431.901,804.00
Accumulated Minority Interest57.4054.4053.7053.8060.5062.80
Total Equity2,343.002,435.802,502.802,510.302,492.401,866.80
Total Liabilities & Stockholders Equity5,828.306,052.906,130.706,241.406,434.906,339.80
Book Value Per Share14.9715.6316.0916.1516.0611.89
Tangible Book Value Per Share0.900.55-0.170.06-0.24-5.37
Full-Time Employees---11,085--
Price to Book Ratio4.163.742.242.932.733.44
Return on Assets-2.01-1.15-0.19-0.14-0.331.30
Return on Equity-5.23-3.40-0.54-0.41-0.994.43
Return on Invested Capital-2.80-1.240.350.58-1.350.18
Quick Ratio0.900.920.720.870.910.70
Current Ratio1.841.851.551.731.851.61

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-109.70-50.9015.7029.20-58.504.20
Depreciation54.1058.0058.3058.1055.7056.10
Other Funds (Non Cash)245.50143.5021.4057.60114.20-11.60
Funds from Operations131.50119.5095.40105.6084.8032.80
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-13.30-196.90-24.20124.20-118.00-160.30
Income Taxes Payable-6.60--36.50-25.20-
Cash from Operating Activities118.20-77.4071.20229.80-33.20-127.50
Capital Expenditures-21.50-28.80-24.20-22.60-20.90-21.30
Net Assets From Acquisitions-57.000.00-16.00-4.20-0.20-68.40
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.00-7.200.000.00
Purchase of Investments0.000.000.00-7.200.000.00
Sale Or Maturity of Investments0.000.000.00-0.000.00
Other Uses0.000.000.00-26.30-2.70-0.40
Other Sources5.803.500.504.800.00-1.00
Cash from Investing Activities-72.70-25.30-39.70-55.50-23.80-91.10
Cash Dividends Paid-18.70-18.50-18.60-7.500.00-7.60
Preferred Dividends (Cash Flow)-11.00-11.00-11.00--0.00
Change in Capital Stock0.000.000.004.00668.304.90
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.004.00668.304.90
Proceedsfrom Stock Options0.000.000.004.00668.304.90
Issuance or Reduction of Debt, Net-57.70167.70-181.30-144.60-416.40102.50
Change in Long Term Debt-57.70167.70-181.30-144.60-416.40102.50
Issuance of Long Term Debt35.00195.000.00-14.40457.30168.30
Reduction of Long Term Debt-92.70-27.30-181.30-130.20-873.70-65.80
Net Financing Active Other Cash Flow-33.700.00-5.00-19.506.50-4.30
Other Financing Activities Uses-33.700.00-5.00-18.405.40-4.30
Cash from Financing Activities-110.10149.20-204.90-167.60258.4095.50
Exchange Rate Effect-0.705.007.90-0.90-0.3031.60
Net Change in Cash-65.3051.50-165.505.80201.10-91.50
Free Cash Flow96.70-106.2047.00207.20-54.10-148.80
Price to Free Cash Flow54.43185.91313.38350.45-332.45

Revenue breakdown

Product2024: 2.76B 2025: 2.77B
Product and Service, Other2024: 607.20M 2025: 670.10M
Asia Pacific Excluding China2024: 518.50M 2025: 552.60M
China2024: 471.20M 2025: 475.80M
Europe Excluding Germany2024: 873.00M 2025: 950.20M
Germany2024: 310.70M 2025: 297.00M
Other Country2024: 254.50M 2025: 269.60M
United States2024: 938.50M 2025: 891.30M
BSI BioSpin2024: 905.70M 2025: 878.80M
BSI CALID2024: 1.09B 2025: 1.21B
Bsi Nano2024: 1.10B 2025: 1.08B
Energy And Supercon Technologies2024: 268.90M 2025: 263.20M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.14%11.3M111.0M2.29M
2026-10-1511.42%12.7M111.0M2.26M
2026-09-3011.18%12.4M111.0M2.23M
2026-09-1511.25%12.5M111.0M2.17M
2026-08-3110.82%12.0M111.0M2.37M
2026-08-1410.62%11.8M111.0M2.50M
2026-07-3111.41%12.7M111.2M2.45M
2026-07-1513.17%14.6M111.1M2.50M
2026-06-3011.35%12.6M111.1M2.42M
2026-06-1511.66%12.9M111.1M2.43M
2026-05-2912.37%13.7M111.1M2.24M
2026-05-1512.07%13.4M111.1M2.18M
2026-04-3011.60%12.8M110.6M2.19M
2026-04-1512.38%12.7M102.8M2.23M
2026-03-3112.19%12.5M102.8M2.44M
2026-03-1310.37%10.7M102.8M2.33M
2026-02-2710.11%10.4M102.8M2.36M
2026-02-1310.56%10.8M102.6M2.39M
2026-01-309.88%10.2M103.2M2.45M
2026-01-159.54%9.8M103.2M2.49M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call32.5029.3031.900.003.8280.000.000.945-0.1720.011
call35.0026.7029.400.003.4810.000.000.937-0.1750.013
call37.5024.3026.900.003.1580.000.000.930-0.1710.014
call40.0021.8024.400.002.8550.000.000.922-0.1670.015
call42.5019.2021.800.002.6140.000.000.914-0.1620.016
call45.0016.8019.400.002.2950.000.000.903-0.1560.018
call47.5014.3017.0014.522.1111.000.000.890-0.1500.019
call50.0011.9014.5011.021.8161.000.000.874-0.1420.021
call52.509.5011.608.501.4276.000.000.839-0.1520.025
call55.007.109.204.801.2229.000.000.793-0.1590.029
call57.505.607.308.261.15175.000.000.711-0.1880.035
call60.003.705.603.151.09021.000.000.622-0.2010.039
call62.502.053.403.450.8585912.000.517-0.1710.041
call65.001.402.101.940.7871,1445.000.397-0.1610.039
call67.500.253.100.500.9906.000.000.337-0.1870.037
call70.000.101.001.350.8373790.000.218-0.1290.030
call72.500.002.300.350.9801500.000.194-0.1410.028
call75.000.002.200.181.1113540.000.177-0.1510.027
call80.000.000.050.051.2927069.000.151-0.1590.024
call85.000.000.050.050.6633120.000.019-0.0160.005
call90.000.000.050.050.7929.000.000.016-0.0170.005
put32.500.000.850.002.9210.000.00-0.055-0.1690.011
put35.000.000.900.002.6820.000.00-0.063-0.1720.013
put37.500.000.900.002.4180.000.00-0.070-0.1680.014
put40.000.000.900.302.1702.000.00-0.077-0.1630.015
put42.500.000.900.001.9350.000.00-0.086-0.1580.016
put45.000.000.900.201.7102.000.00-0.097-0.1520.018
put47.500.000.900.551.49554.000.00-0.110-0.1450.019
put50.000.000.900.191.2862.000.00-0.125-0.1370.021
put52.500.001.100.531.1021670.00-0.150-0.1320.024
put55.000.001.350.301.0391,0080.00-0.207-0.1530.029
put57.500.052.050.401.0222560.00-0.289-0.1820.035
put60.000.252.802.450.96123.000.00-0.379-0.2000.039
put62.501.303.202.600.7606.000.00-0.483-0.1640.041
put65.002.804.907.200.8131.000.00-0.602-0.1550.039
put67.504.506.700.000.8280.000.00-0.663-0.1800.037
put70.006.608.8015.400.8741.000.00-0.782-0.1220.030
put72.508.9011.000.000.9110.000.00-0.806-0.1340.028
put75.0010.7013.400.000.9970.000.00-0.823-0.1430.027
put80.0015.6018.300.001.1750.000.00-0.981-0.0090.005
put85.0020.6023.300.001.3730.000.00-0.983-0.0100.004
put90.0025.6028.300.001.5540.000.00-0.985-0.0100.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-058-KCurrent report2026-11-05SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-09SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-09SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-09SEC
2026-08-06SCHEDULE 13G/ASEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-308-KCurrent report2026-07-30SEC
2026-07-164Statement of changes in beneficial ownership of securities2026-07-15SEC
2026-07-15144Filing for proposed sale of securities under Rule 144.SEC
2026-07-103Initial statement of beneficial ownership of securities2026-07-01SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900105.74K1
2026-0800312.81K2
2026-0700120.50K1
2026-0600109.52K1
2026-050087.80K1
2026-040079.80K1
2026-030070.88K1
2026-020073.88K1
2026-01002.16M3
2025-1200243.23K1
2025-1100243.09K1

Institutional holders

Manager% owned
FMR LLC13.32%
Orbis Allan Gray Ltd11.79%
BlackRock, Inc.7.49%
Pallas Capital Advisors LLC6.23%
VANGUARD PORTFOLIO MANAGEMENT LLC3.21%
VANGUARD CAPITAL MANAGEMENT LLC3.19%
Sculptor Capital LP3.04%
STATE STREET CORP2.64%
FRANKLIN RESOURCES INC2.12%
Sachem Head Capital Management LP1.91%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF2.50%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.22%
VANGUARD SMALL-CAP INDEX FUND1.61%
Global Equity Fund1.60%
First Trust NYSE Arca Biotechnology Index Fund1.33%
Touchstone Funds Group Trust-Touchstone Mid Cap Fund1.26%
T. Rowe Price All-Cap Opportunities Fund1.16%
VANGUARD SMALL-CAP VALUE INDEX FUND1.02%
Franklin Small Cap Value Fund0.93%
VANGUARD EXTENDED MARKET INDEX FUND0.84%

OakChart. BRKR. Cached 15 minutes.